SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-17-006829
Filing Date
2017-01-10
Accepted
2017-01-10 16:06:56
Documents
1
Group Members
ANDREW G. BLUHMDSC ADVISORS, L.L.C.DSC ADVISORS, L.P.DSC MANAGERS, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d218925dsc13ga.htm SC 13G/A 83619
  Complete submission text file 0001193125-17-006829.txt   85325
Mailing Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241
Business Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Subject) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88808 | Film No.: 17520656
SIC: 2834 Pharmaceutical Preparations

Mailing Address 900 N. MICHIGAN, SUITE 1600 CHICAGO IL 60611
Business Address 900 N. MICHIGAN, SUITE 1600 CHICAGO IL 60611 312-915-2886
Delaware Street Capital Master Fund, L.P. (Filed by) CIK: 0001648576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A